Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

6 677 evidences · page 195 / 268

97 %S. aureus showed excellent susceptibility to vancomycin at 97%.

Kenyaantimicrobial resistanceobservé 2015publié 2019PloS oneeurope_pmcdocument de 14 observationsDOI 10.1371/journal.pone.0212131

2,15 USD_per_client_monthThe estimated financial cost per client-month on PEP was $2.15 USD for subsidized delivery.

KenyaVIH/sidapublié 2025BMC health services researchPubMeddocument de 13 observations

9,4 %HPV vaccination coverage was 9.4% among adolescent girls in Western Kenya.

Kenyainfection à HPVpublié 2021The Pan African medical journalPubMeddocument de 5 observations

6,3 %The prevalence of symptomatic urinary tract infection among adult HIV-positive outpatients at Embu County Referral Hospital, Kenya, was 6.3% in January–February 2023.

Kenyainfection urinaireobservé January to February 2023publié 2025BMC microbiologyPubMeddocument de 16 observations

50,9 %The condom programme for men who have sex with men had availability coverage of 50.9%.

KenyaVIH/sidaobservé 2023publié 2024Journal of the International AIDS SocietyPubMeddocument de 10 observations

32,2 %Among 115 gbMSM in Nairobi, Kenya, one-third (32.2%) had high-risk HPV (HR-HPV).

Kenyainfection à HPVpublié 2023Cancer medicinePubMeddocument de 7 observations

16,1 %Combined Chlamydia trachomatis and/or Neisseria gonorrhoeae infection was detected in 16.1% of men aged 18–39 years engaged in transactional sex and alcohol use in Siaya County, Kenya.

KenyaChlamydia trachomatis and/or Neisseria gonorrhoeaepublié 2025Sexually transmitted infectionsPubMeddocument de 12 observations

52 %Of the 52 parasitemic individuals at enrollment, 52% (27/52) were newly diagnosed HIV-1 positive.

Kenyapaludismepublié 2023The American journal of tropical medicine and hygienePubMeddocument de 6 observations

68 contactsAs of 30 September 2024, Kenya had listed 68 mpox contacts, with 61 completing the 21-day follow-up period and one contact developing symptoms and testing positive.

Kenyampoxobservé 30 September 2024Africa CDCdocument de 147 observations

Urban areas systematically have lower Pf PR 2-10 than rural areas, with urban values ranging from 5% to 30% and rural values ranging from 15% to 40%.

Kenyapaludismepublié 2020Environmental research letters : ERL [Web site]europe_pmcdocument de 2 observations

317 mothersIn the study, 317 rural and urban Mijikenda mothers reported responses to childhood fevers in the last 2 weeks.

Kenyachildhood feversobservé last 2 weekspublié 2002Journal of biosocial scienceeurope_pmcdocument de 3 observations

90 %More than 90% of gestational diabetes cases are estimated to occur in low-income and middle-income countries.

Kenyagestational diabetespublié 2024The lancet. Diabetes & endocrinologyPubMeddocument de 8 observations

62,7 %The prevalence of anemia in pregnancy (AiP) among asymptomatic pregnant women attending antenatal care at Msambweni Hospital was 62.7%.

Kenyaanémieobservé September 2018 to February 2019publié 2020PloS onePubMeddocument de 7 observations

76,9 %76.9% of HIV-infected adolescents and young adults achieved viral suppression (viral load <1000 copies/ml).

KenyaVIH/sidapublié 2021African health sciencesPubMeddocument de 5 observations

33,4 per_100000In Harare, Zimbabwe, the age-standardized incidence rate of oesophageal cancer was 33.4 per 100,000 in males and 25.3 per 100,000 in females between 2004 and 2008.

Kenyaoesophageal cancerobservé 2004–2008publié 2015Cancer epidemiologyeurope_pmcdocument de 10 observationsDOI 10.1016/j.canep.2015.01.001

7,1 SMRThe median standardized mortality ratio (SMR) for epilepsy was 7.1.

Kenyaépilepsiepublié 2021Frontiers in neurologyeurope_pmcdocument de 5 observations

85 %The prevalence of coronary artery disease in Asian patients with heart failure with reduced ejection fraction was 85%.

Kenyacoronary artery disease · insuffisance cardiaquepublié 2023Global heartPubMeddocument de 8 observations

1,94 odds_ratioIn a cohort of 309 adolescent girls and young women aged 15–24 years living with HIV in Kisumu County, western Kenya, experiences of emotional violence were associated with significantly higher odds of poor antiretroviral therapy adherence (Odds Ratio = 1.94).

KenyaVIH/sidaobservé January to June 2022publié 2023International journal of environmental research and public healthPubMeddocument de 4 observations

80 %The sensitivity of C-reactive protein ≥3.3 mg/L for identifying pulmonary tuberculosis was 80% among people living with HIV receiving antiretroviral therapy in western Kenya.

Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 12 observations

47,6 %Among participants with high-risk HPV genotypes (n=82), 47.6% (39/82) were coinfected with HIV.

Kenyainfection à HPV · VIH/sidapublié 2022BMC infectious diseasesPubMeddocument de 4 observations

85,6 %At 12 months postpartum, 1140 (85.6%) women were retained in care, 96 women (7.2%) were lost-to-follow-up (LTFU), and 95 (7.1%) were discontinued from the study.

KenyaVIH/sidapublié 2022Journal of the International AIDS Societyeurope_pmcdocument de 5 observations

100 %E. coli, Shigella and Salmonella isolates showed up to 100% level of resistance to ampicillin.

KenyaE. coli · Salmonella · Shigellapublié 2019African Journal of Health SciencesOpenAlexdocument de 18 observations

30 %An estimated 30–50% of residents in the major urban counties of Kenya were infected during the first wave of SARS-CoV-2 transmission.

KenyaCOVID-19observé up to the end of September 2020publié 2021Wellcome open researcheurope_pmcdocument de 2 observations

75 %At enrollment, 75% of participants wanted male partners to attend PMTCT appointments.

KenyaVIH/sidapublié 2021AIDS carePubMeddocument de 7 observations

255 individualsOf 283 reported seroconversions on PrEP, 255 (90%) individuals enrolled in GEMS.

KenyaVIH/sidaobservé December 2017 through September 2023publié 2025Journal of the International AIDS SocietyPubMeddocument de 13 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.